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ABSTRACT
Background. Results of previous research examining long-term residual eﬀects of marijuana use
on cognition are conﬂicting. A major methodological limitation of prior studies is the inability
to determine whether diﬀerences between users and non-users are due to diﬀerences in genetic
vulnerability preceding drug use or due to the eﬀects of the drug.
Method. Fifty-four monozygotic male twin pairs, discordant for regular marijuana use in which
neither twin used any other illicit drug regularly, were recruited from the Vietnam Era Twin
Registry. A minimum of 1 year had passed since the marijuana-using twins had last used the drug,
and a mean of almost 20 years had passed since the last time marijuana had been used regularly.
Twins were administered a comprehensive neuropsychological test battery to assess general intel-
ligence, executive functioning, attention, memory and motor skills. Diﬀerences in performance
between marijuana-using twins and their non-using co-twins were compared using a multivariate
analysis of speciﬁc cognitive domains and univariate analyses of individual test scores. Dose–
response relationships were explored within the marijuana-using group.
Results. Marijuana-using twins signiﬁcantly diﬀered from their non-using co-twins on the general
intelligence domain; however, within that domain only the performance of the block design subtest
of the Wechsler Adult Intelligence Scale – Revised reached a level of statistical signiﬁcance.
Conclusions. Out of the numerous measures that were administered, only one signiﬁcant diﬀerence
was noted between marijuana-using twins and their non-using co-twins on cognitive functioning.
The results indicate an absence of marked long-term residual eﬀects of marijuana use on cognitive
abilities.
INTRODUCTION
A recent meta-analysis of research relating to the
residual neuropsychological eﬀects of marijuana
use found no evidence for signiﬁcant long-term
eﬀects of the drug on neurocognitive processes ;
however, the authors noted that many of the
studies included in the analysis had signiﬁcant
methodological shortcomings that limited the
generalizability of the ﬁndings (Grant et al.
2003). An earlier qualitative review by the same
group concluded that most studies were too
fraught with methodological ﬂaws to provide
clear evidence as to the nature of the eﬀect
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(Gonzalez et al. 2002). Among those studies
reviewed, 55% found evidence for subtle cog-
nitive impairments in marijuana users, ranging
across a variety of speciﬁc neuropsychological
domains. The most striking ﬁnding, however,
was that of the 40 studies included in the survey,
only 13 were able to meet all of the seven mini-
mal methodological requirements articulated
by the authors. These included the utilization
of a control group, controlling for a history of
neurological or psychiatric disorders, and the
establishment of an abstinence period before
neuropsychological testing. An earlier literature
review reached a similar conclusion and argued
for the use of more sophisticated research de-
signs, as well as wide-ranging assessment bat-
teries (Pope et al. 1995).
While several studies have been conducted
with more sound methodologies, ﬁndings are
inconsistent regarding the extent of the long-
term cognitive impairments associated with
marijuana use. Solowij et al. (2002) found evi-
dence for memory and attention impairments
in long-term marijuana users compared to
non-using controls after a minimum 12-hour
abstinence period. Pope et al. (2002) found
similar memory impairments up to 7 days after
marijuana use ceased, but were unable to ﬁnd a
signiﬁcant diﬀerence between users and controls
after 28 days of abstinence. Other studies pro-
vide mixed evidence regarding residual neuro-
psychological deﬁcits resulting from marijuana
use (Mendhiratta et al. 1988; Schwartz et al.
1989; Solowij et al. 1991; Lyketsos et al. 1999;
Varma et al. 2000). Where diﬀerences between
users and non-users have been found, they are
often on only one or two tests out of a large
number administered; moreover, the diﬀerences
are often modest, and users’ scores are usually
within the range of normal cognitive variability
(Block & Ghoneim, 1993).
The present study compares monozygotic
twin pairs, who are discordant for regular
marijuana use, on a broad spectrum of neuro-
psychological tests. Such a design has been re-
ferred to repeatedly in the literature as an ideal
way of assessing the neuropsychological eﬀects
of marijuana while controlling for cognitive
deﬁcits that could be related to an underlying
genetic vulnerability to substance use (Pope et al.
1995; Gonzalez et al. 2002; Grant et al. 2003).
Since monozygotic twins share 100% of their
genes and many of the same childhood environ-
mental experiences, this design can control
for many of the confounding factors that have
made previous results inconclusive.
METHOD
Participants
Study participants were members of the
Vietnam Era Twin (VET) registry. The registry,
assembled from a Department of Defense com-
puter ﬁle of 5.5 million veterans, comprises
male–male twin pairs born between 1939 and
1957 in which both members served in the mili-
tary during the Vietnam War era (1965–1975).
Twin siblings were identiﬁed by matching
veterans for same last name, date of birth and
similar social security number, and conﬁrmed
by examination of military service records.
Zygosity was assigned using responses to a series
of questions about similarity of physical appear-
ance, supplemented with blood group typing
information. A complete description of registry
construction (Eisen et al. 1987), characteristics
of registry members (Henderson et al. 1990), and
method of zygosity determination (Eisen et al.
1989) have been provided in detail elsewhere.
Drug use data collected previously by our
group in the course of the Harvard Twin Study
of Drug Abuse and Dependence were available
from 1806 pairs of identical twins from the VET
registry (Tsuang et al. 2001). Participants were
interviewed by telephone using the Diagnostic
Interview Schedule, Version III – Revised (DIS-
III-R; Robins et al. 1988). This permitted life-
time psychiatric diagnoses to be made for a wide
variety of disorders according to the Diagnostic
and Statistical Manual for Mental Disorders,
Third Edition Revised criteria (DSM-III-R;
APA, 1987). Using these data, 117 monozygotic
twin pairs (234 individuals) were identiﬁed who
met the following criteria : (1) one twin used
marijuana at least once weekly for a minimum
of 1 year, while his co-twin never used mari-
juana more than ﬁve times in his life ; (2) the
marijuana-using twin reported not using mari-
juana for at least 1 month prior to the DIS-III-R
telephone interview; (3) neither sibling reported
regularly using, at least once weekly, any other
illicit drug; and (4) neither sibling reported ever
experiencing symptoms of alcohol withdrawal
(e.g. ‘shakes’, diﬃculty sleeping, feeling anxious
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or depressed, sweating, rapid heart beat, de-
lirium tremens, hallucinations, seizures). Twin
pairs in which either one or both siblings
reported alcohol withdrawal symptoms were
excluded because of concern that the adverse
health consequences associated with very heavy
alcohol use might complicate the attempt to
identify the adverse eﬀects of marijuana (Fadda
& Rossetti, 1998).
Recruitment letters were mailed in 1995 to
eligible members of the VET Registry. The
62 twin pairs who agreed to be examined were
oﬀered the opportunity to travel to one of two
research sites, Boston (Harvard University) or
St Louis (Washington University), or the option
of having a research assistant travel to their
hometown for an evaluation at a local hotel.
Travel and hotel costs associated with par-
ticipation were paid by the study, and $225
compensation was oﬀered. Before the in-person
evaluation, a research assistant explained the
research procedures and obtained written in-
formed consent. This method of consent was
approved by all appropriate institutional review
boards.
In total, data from eight twin pairs were
eliminated from the analysis for the following
reasons. Five twin pairs were removed because
one sibling had used marijuana within the pre-
ceding 12 months. Another pair was excluded
because one member had been misclassiﬁed as
a non-user. One pair was excluded because one
of the twins had experienced a stroke and had
been treated for it surgically. A ﬁnal pair was
excluded because one of the twins had AIDS
and a history of a psychotic illness. The present




The minimum number of days on which mari-
juana was used during the participant’s lifetime
was derived from responses to the following
DIS-III-R questions administered in 1992:
‘Have you ever used marijuana (hashish, bhang,
ganja)? ’ ‘Have you ever used marijuana (hash-
ish, bhang, ganja) more than ﬁve times?’ ‘Have
you ever used marijuana (hashish, bhang, ganja)
regularly, that is, once a week or more? ’ ‘How
many days per week did you use marijuana
during your period of most frequent use?’ ‘How
old were you when you started your period of
most frequent use? ’ ‘How old were you when
you ended your period of most frequent use?’
and ‘What was the longest period that you used
marijuana almost every day?’
The minimum number of days on which
marijuana was used was the greater of the
following calculations : (a) number of days per
week marijuana was used during the period of
most frequent use multiplied by the number of
weeks that period lasted, or (b) the total number
of weeks of regular marijuana use, assuming one
use per week. Days of marijuana use between
1992 and the present study, 1995–1996, were
added to the minimum number of days used.
Neuropsychological tests
Participants were administered a comprehensive
neuropsychological test battery by a research
assistant blind to the twin’s drug use history.
Neuropsychological tests were chosen to assess
the following cognitive domains: general in-
telligence, attention, memory, executive func-
tioning and motor skills. Table 1 shows a
breakdown of the neuropsychological tests
used in each domain. General intelligence was
assessed with the Wechsler Adult Intelligence
Table 1. Neuropsychological assessment
battery
Cognitive domain Measure
General intelligence Wechsler Adult Intelligence
Scale – Revised
Raven’s Advanced Progressive
Matrices – Set I
Wide Range Achievement Test – Revised
Attention Cancellation Test, Verbal and Nonverbal
Time
Continuous Performance Task, AX and
X-degraded conditions
Trail Making Test, Part A
Memory Wechsler Memory Scale – Revised, logical
memory and visual reproduction
California Verbal Learning Test
Rey–Osterrieth Complex Figure Test,
accuracy scores
Executive functioning Wisconsin Card Sorting Test
Stroop Test, Color/Word Score
Cancellation Test, Organization Scores
Trail Making Test, B – A
Rey–Osterrieth Complex Figure Test,
organization scores
Motor skills Finger Tapping Test (FTT)
Grooved Pegboard
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Scale – Revised (WAIS-R) Verbal, Performance
and Full Scale IQ scores, as well as subtest
scaled scores (Wechsler, 1981). This domain
also included a measure of general nonverbal
problem solving as assessed by the number
correct from the Raven’s Advanced Progressive
Matrices – Set I (Raven, 1982) ; and a measure
of reading achievement as assessed by the
standard score from the Wide Range Achieve-
ment Test – Revised (WRAT-R; Jastak &
Wilkinson, 1984). Attention was assessed with
the Cancellations Test time and organization
scores of the visual attention and speed/random
verbal and non-verbal conditions (Mesulam,
1985) ; Trail Making Test, time score for part A;
and the Continuous Performance Test (CPT),
mean reaction time, number correct, omissions,
number incorrect, omissions and sensitivity for
both AX- and X-degraded conditions (Rosvold
et al. 1956; Davies & Parasuraman, 1982). The
memory domain was assessed with the Wechsler
Memory Scale – Revised (WMS-R), recall for
the immediate and delayed conditions of the
Logical Memory and Visual Reproductions
subtests (Wechsler, 1987) ; the California Verbal
Learning Test (CVLT), list A total trials 1–5,
short delay free and cued recall, long delay
free and cued recall, and recognition hits (Delis
et al. 1987) ; and the Rey–Osterrieth Complex
Figure Test, accuracy scores for the copy, im-
mediate and delayed recall conditions (Rey,
1941; Osterrieth, 1944). Executive functioning
was assessed with the Wisconsin Card Sorting
Test (WCST), number of categories and per-
severative errors (Heaton, 1981) ; the Stroop
Test, age-corrected T score for the Color/Word
condition (Stroop, 1935) ; Trail Making Test,
time score for part B – part A; and the Rey–
Osterrieth Complex Figure Test, organization
score for the copy, immediate and delayed
recall conditions (Rey, 1941; Osterrieth, 1944).
Finally, the motor skills domain was assessed by
the Finger Tapping Test (FTT), the average
number of taps across trials for the dominant
and non-dominant hands (Halstead, 1947) ; and
the Grooved Pegboard, time for the dominant
and non-dominant hands (Matthews & Klove,
1964).
Statistical analyses
Demographic diﬀerences between marijuana
using and non-using twin pair members were
examined using McNemar’s x2 test for paired
proportions for dichotomous response vari-
ables, and the matched pairs t test for continu-
ous variables. Intra-pair median diﬀerences of
ordinal scale variables were evaluated using the
Wilcoxon signed rank test. To assess for a non-
response bias, data collected in 1992 from the
54 pairs who participated in the present study
were compared with data from the 55 twin pairs
who chose not to participate for diﬀerences in
age, race, employment status, educational level,
alcohol abuse/dependence status and marijuana
days of use as of 1992. The two groups were
also compared for the lifetime prevalence of
the following psychiatric disorders: alcohol and
nicotine abuse or dependence, mania, bipolar
disorder, major depression, dysthymia, general-
ized anxiety disorder, pathological gambling
and panic disorder.
To control for multiple tests, we took a
sequential approach to comparing the mari-
juana users to their non-using co-twins. We ﬁrst
examined diﬀerences on the ﬁve neuropsycho-
logical domains between using and non-using
twin-pair members using a multivariate ap-
proach with a repeated-measures general linear
model. This model used each pair as a case and
the two members of the pair as the within-
subjects factor. If the multivariate test of a
neuropsychological domain was signiﬁcant, we
followed this with a univariate approach. First,
we used the Kolmogorov–Smirnov test to deter-
mine whether the neuropsychological test scores
were normally distributed. For those scores that
were normally distributed, we compared groups
using matched-pairs t tests. For those scores
that were not normally distributed, we compared
groups using the Wilcoxon signed rank tests.
Within the user group, dose-response relation-
ships between the number of days of marijuana
use and neuropsychological test scores were
examined using Pearson correlation coeﬃcients
for normally distributed variables and Spear-
man correlation coeﬃcients for those that were
not normally distributed. Signiﬁcance levels
were set at p<0.05 (two-tailed) for all analyses.
In order for the diﬀerence between marijuana
users and non-users on a speciﬁc measure to be
formally designated as ‘signiﬁcant’, we required
that the multivariate test of the domain achieve
statistical signiﬁcance and that the follow-up
univariate test of the individual measure also
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achieve signiﬁcance. Given the widespread a
priori expectation that marijuana has adverse
eﬀects on cognitive functioning, we wanted to
balance the risk of type I error (incorrectly
concluding that marijuana users were signiﬁ-
cantly diﬀerent from their non-using co-twins)
with the risk of type II error (incorrectly con-
cluding that marijuana users did not diﬀer
from their non-using co-twins). In general, a
conservative scientiﬁc approach places a higher
priority on the avoidance of type I error; how-
ever, we wanted to balance this against the risk
of missing actual diﬀerences that did exist and
making a type II error. Therefore, we calculated
the means and eﬀect sizes along with the nom-
inal statistical signiﬁcance of every possible
univariate test comparing marijuana using twins
to their non-using co-twins.
We did not consider univariate tests to reach
our criterion for statistical signiﬁcance if the
multivariate signiﬁcance test of the domain to
which they belong did not reach statistical sig-
niﬁcance. However, in the interest of providing
readers with as much relevant information as
possible, we chose to report the nominal prob-
ability of each univariate test. Because these
values are not adjusted for the numerous com-
parisons that we conducted, we do not consider
a probability below 0.05 to be statistically sig-
niﬁcant. These probabilities are presented for
descriptive, not inferential, purposes. Our group
has successfully used this method in a similar
study of twins discordant for stimulant use
(Toomey et al. 2003).
RESULTS
At the time of neuropsychological assessment,
participants’ ages ranged from 38 to 51 years
(mean=46.3¡3.1). Former marijuana users
were not signiﬁcantly diﬀerent from their co-
twins in the proportion who were currently
married (users 79.2%, non-users 81.5%; x2=
0.08, p=0.78) or employed (users 98.1%, non-
users 94.4%; x2=1.0, p=0.31), and were in
the same median household income bracket
($50,001–$60,000, Z=x0.93, p=0.35). Edu-
cation level did not diﬀer between the two
groups (users 13.9 years, non-users 14.3 years,
Z=x1.49, p=0.14), nor did the groups diﬀer
on indicators of learning problems in school
such as being in a special school (0 users, 3 non-
users), being in a special academic class (users
11.1%, non-users 3.7%; x2=2.67, p=0.10), or
getting special help for academic problems
(users 14.8%, non-users 18.5%; x2=0.40,
p=0.52). In the user group, no subject reported
ever being diagnosed with a learning disability
or with attention deﬁcit disorder. In the non-
user group, one subject reported having been
diagnosed with a learning disability and one
subject reported having been diagnosed with
attention deﬁcit disorder. The groups did not
diﬀer in having ever had a head injury (users
53.7%, non-users 46.3%; x2=0.62, p=0.43).
No signiﬁcant diﬀerences were observed be-
tween former marijuana users and their non-
using co-twins in lifetime prevalence of alcohol
abuse/dependence (users 63.0%, non-users
51.9%; x2=1.64, p=0.20), total number of
years drinking alcohol (users 24.1, non-users
23.9; t=0.14, p=0.89), proportion of current
drinkers (users 74.0%, non-users 69.2%; x2=
0.29, p=0.59), and average number of drinks
per day during the preceding year among
currently drinking twins (users 0.92, non-users
0.66; t=1.64, p=0.11). No signiﬁcant diﬀer-
ences were observed between former marijuana
users and non-users in lifetime prevalence of
Table 2. Number of lifetime marijuana use














Table 3. Repeated measures MANOVA com-
paring marijuana users and non-users on neuro-
psychological tests
Cognitive domain F value p value
General intelligence (n=53) 1.96867 0.045*
Attention (n=49) 0.49116 0.92
Memory (n=52) 1.06870 0.41
Executive functioning (n=53) 1.17883 0.33
Motor skills (n=53) 1.27812 0.29
* p<0.05.
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Verbal IQ 106.00 (11.63) 107.06 (11.77) t=x1.03 0.31 0.09
Performance IQ 109.83 (13.27) 107.54 (13.29) t=1.76 0.09 0.17
Full Scale IQ 107.98 (12.74) 108.13 (12.94) t=x0.14 0.89 0.01
Information Scaled Score 10.81 (2.13) 10.94 (2.51) t=x0.60 0.55 0.06
Digit Span Scaled Score 10.81 (2.43) 10.30 (2.45) t=1.60 0.12 0.20
Vocabulary Scaled Score 10.91 (2.18) 10.93 (2.46) z=x0.12 0.91 0.01
Arithmetic Scaled Score 10.35 (2.84) 10.78 (2.92) z=x1.15 0.25 0.15
Comprehension Scaled Score 11.06 (2.62) 11.44 (2.25) t=x1.06 0.29 0.12
Similarities Scaled Score 10.04 (2.50) 10.43 (2.45) t=x0.99 0.33 0.16
Picture Completion Scaled Score 10.41 (2.29) 10.00 (2.55) t=1.08 0.29 0.17
Picture Arrangement Scaled Score 10.85 (2.61) 10.17 (2.89) t=1.84 0.07 0.25
Block Design Scaled Score 10.22 (2.54) 10.70 (2.48) t=x1.97 0.05* 0.19
Object Assembly Scaled Score 9.80 (2.47) 9.65 (2.63) t=0.49 0.63 0.06
Digit Symbol Scaled Score 8.89 (2.02) 8.69 (2.21) z=0.58 0.56 0.09
Raven’s
Number correct 8.28 (2.13) 8.51 (2.23) t=x0.69 0.50 0.11
WRAT-R
Reading Standard Score 97.31 (10.63) 95.69 (12.43) t=1.71 0.09 0.14
Attention
Cancellation test
Nonverbal, time in seconds 99.33 (28.33) 103.30 (31.40) t=x0.83 0.41 0.13
Verbal, time in seconds 108.89 (31.32) 107.31 (31.18) t=0.37 0.71 0.05
CPT
X-degraded, reaction time (seconds) 48.36 (7.28) 47.31 (9.44) z=x0.19 0.85 0.12
X-degraded, number correct 46 (19.22) 46.69 (18.58) t=x0.46 0.65 0.04
X-degraded, omissions 27.73 (18.93) 26.82 (18.23) t=0.60 0.53 0.05
X-degraded, number incorrect 20.06 (14.88) 23.92 (24.21) z=x0.87 0.38 0.19
X-degraded, sensitivity 0.8422 (0.141) 0.8417 (0.150) z=0.00 1.00 0.00
AX, reaction time (seconds) 33.72 (4.91) 34.20 (6.14) t=x0.51 0.61 0.09
AX, number correct 73.76 (3.15) 73.06 (5.21) z=x0.85 0.40 0.16
AX, omissions 1.96 (3.05) 2.63 (5.09) z=x0.83 0.41 0.16
AX, number incorrect 3.39 (6.09) 3.80 (6.50) z=x0.23 0.82 0.07
AX, sensitivity 0.9902 (0.012) 0.9872 (0.022) z=x0.71 0.48 0.17
Trail Making Test
Part A, time in seconds 31.35 (9.42) 31.83 (9.23) t=x0.30 0.76 0.05
Memory
WMS-R
Logical memory, immediate recall 24.74 (5.57) 25.15 (5.46) t=x0.52 0.60 0.07
Logical memory, delayed recall 21.75 (6.51) 22.04 (6.46) t=x0.29 0.77 0.04
Visual reproduction, immediate recall 33.50 (4.10) 33.78 (3.42) z=x0.21 0.84 0.07
Visual reproduction, delayed recall 30.93 (5.55) 29.87 (6.33) t=1.09 0.28 0.18
CVLT
Trials 1–5, total correct 46.04 (8.14) 47.60 (8.46) t=x1.10 0.28 0.198
List B, total correct 5.77 (1.59) 6.08 (1.45) z=x0.94 0.35 0.20
Short delay free recall, no. correct 9.55 (2.42) 9.40 (2.53) t=0.37 0.71 0.06
Short delay cued recall, no. correct 10.92 (2.27) 11.00 (2.43) t=x0.20 0.84 0.03
Long delay free recall, no. correct 9.91 (2.41) 10.66 (2.51) t=x2.22 0.03 0.31
Long delay cued recall, no. correct 10.72 (2.27) 11.38 (2.42) t=x1.86 0.07 0.28
Recognition hits 14.38 (1.71) 14.53 (1.56) z=x0.39 0.70 0.09
Rey-Osterrieth
Copy accuracy 64.65 (0.76) 64.70 (0.72) z=x0.40 0.69 0.07
Immediate recall accuracy 50.11 (8.28) 50.93 (7.82) t=x0.87 0.39 0.11
Delayed recall accuracy 49.52 (9.55) 50.96 (8.08) t=x1.26 0.21 0.16
Executive functioning
WCST
Categories completed 4.93 (1.90) 4.65 (1.85) z=x0.90 0.37 0.15
Perseverative errors 16.87 (13.94) 15.70 (9.95) z=x0.51 0.61 0.10
Stroop Test
Color/word, age-corrected raw score 45.77 (8.60) 43.83 (8.43) t=1.42 0.16 0.23
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nicotine dependence (users 50.0%, non-users
53.7%; x2=0.29, p=0.59).
Twin pairs that chose to participate in this
study did not signiﬁcantly diﬀer from twins
that did not participate in terms of age, race,
employment status, education level, alcohol
abuse/dependence, marijuana use days as of
1992, and the lifetime prevalence of the follow-
ing psychiatric disorders : alcohol abuse/depen-
dence, nicotine dependence, mania, bipolar
disorder, major depression, dysthymia, general-
ized anxiety disorder, pathological gambling and
panic disorder.
Among the marijuana-using members of the
54 twin pairs, 37% reported using marijuana a
minimum of between 52 and 300 days during
their lifetime, 39% a minimum of between 301
and 1000 days, and 24% a minimum of between
1001 and 7000 days (Table 2). The mean number
of days on which marijuana was used was 916
(S.D.=1201). The mean age of initiating regular
marijuana use was 21.3¡3.8 years (range=
17–38 years), of last regular marijuana use was
27.1¡6.0 years (range=19–43 years), and the
mean duration of regular marijuana use was
5.8¡5.3 years (range=1–22 years).
As would be expected from previous twin
research on cognitive abilities, we observed a
substantial degree of resemblance within twin
pairs (Cardon & Fulker, 1993). Cross-twin cor-
relations for the WAIS-R Full Scale (r=0.82),
Verbal (r=0.79), Performance (r=0.74), and all
11 subtests (range=0.32–0.78) were signiﬁcant
at the p<0.01 level (except for Similarities and
Picture Arrangement, which were signiﬁcant at
the p<0.05 level), as was the WRAT-R Reading
standard score (r=0.83). Cross-twin corre-
lations for WCST (range=0.38–0.42) and FTT
(range=0.36–0.41) scores were all signiﬁcant at
the p<0.01 level. Correlations for three CVLT
scores were signiﬁcant at the p<0.01 level, two
at the p<0.05 level, while two did not attain
statistical signiﬁcance (range=0.09–0.56).
Table 3 presents the results from the multi-
variate analysis of the ﬁve cognitive domains.
Of these domains, only general intelligence was
found to diﬀer signiﬁcantly between marijuana
users and non-users (F=1.968; p=0.045). Uni-
variate analyses of the speciﬁc measures in-
dicated that only one reached our criterion for
statistical signiﬁcance (Table 4). An inspection
of univariate analyses in all of the domains
indicated that very few had a nominal p value
less than 0.05. Marijuana users performed sig-
niﬁcantly worse than non-users on the WAIS-R
block design subtest (t=x1.97; p=0.05). The
CVLT long delay free recall (t=x2.22; p=















Nonverbal, organization score 1.76 (0.75) 1.78 (0.69) z=x0.16 0.88 0.03
Verbal, organization score 1.65 (0.83) 1.59 (0.71) z=x0.47 0.64 0.08
Trail Making Test
B – A, time in seconds 67.56 (35.33) 68.83 (33.08) z=x0.27 0.78 0.04
Rey-Osterrieth
Copy organization 10.91 (2.26) 10.52 (3.09) z=x0.50 0.62 0.14
Immediate recall organization 9.87 (3.35) 10.26 (2.71) z=x0.40 0.69 0.13
Delayed recall organization 10.00 (3.38) 10.61 (2.21) z=x0.90 0.37 0.21
Motor skills
Finger Tapping
Average dominant hand 54.03 (5.41) 55.42 (6.44) t=x1.50 0.14 0.23
Average non-dominant hand 48.17 (4.43) 49.99 (6.58) t=x2.11 0.04 0.32
Grooved Pegboard
Time, dominant hand 71.90 (7.08) 70.84 (9.59) t=0.81 0.42 0.13
Time, non-dominant hand 75.74 (10.12) 73.74 (9.61) t=1.46 0.15 0.20
CPT, Continuous Performance Task; CVLT, California Verbal Learning Test ; WAIS-R, Wechsler Adult Intelligence Scale Revised;
WCST, Wisconsin Card Sorting Test; WMS-R, Wechsler Memory Scale – Revised; WRAT-R, Wide Range Achievement Test – Revised.
* p<0.05.
# For variables that were normally distributed, paired-samples t tests were conducted and the t value was reported. For variables that were
not normally distributed in either one or both groups, Wilcoxon signed rank tests were conducted, and the z value was reported.
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hand on Finger Tapping (t=x2.11; p=0.04)
did not meet our ﬁrst criterion for signiﬁcance,
but did have nominal p values less than 0.05.
Based on the nominal p values there was a
‘trend’ (0.05<p<0.10) for users to perform
worse than non-users on the CVLT long delay
cued recall (t=x1.86; p=0.07). Also based on
nominal p values, ‘ trends’ for users to perform
better than non-users were observed for the
WAIS-R performance IQ (t=1.76; p=0.09),
the WAIS-R picture arrangement (t=1.84; p=
0.07), and the WRAT-R reading (t=1.71;
p=0.09).
The correlation of total days of marijuana
use and neuropsychological test performance
(Table 5) revealed no signiﬁcant dose response
eﬀects. Analysis of the distribution of scores for
total days of marijuana use revealed one case
to be a signiﬁcant outlier from the rest of the
sample (6188 marijuana use days; 4 S.D. above
the mean). Inclusion of this case in the dose–
response analysis resulted in signiﬁcant corre-
lations with the number of correct responses
(r=x0.29; p=0.03) and the number of omis-
sions (r=0.31; p=0.02) on the CPT AX con-
dition. The removal of this case from the dose–
response analysis resulted in non-signiﬁcant
Table 5. Correlation of total days of marijuana





coeﬃcients, r p value
General intelligence
WAIS-R
Verbal IQ 0.102 0.469
Performance IQ x0.053 0.706
Full Scale IQ 0.046 0.742
Information Scaled Score 0.152 0.276
Digit Span Scaled Score 0.012 0.930
Vocabulary Scaled Score# 0.057 0.686
Arithmetic Scaled Score# x0.046 0.744
Comprehension Scaled Score 0.199 0.154
Similarities Scaled Score 0.056 0.690
Picture Completion Scaled Score 0.142 0.311
Picture Arrangement Scaled Score x0.156 0.264
Block Design Scaled Score 0.060 0.671
Object Assembly Scaled Score 0.010 0.945
Digit Symbol Scaled Score# x0.004 0.976
Raven’s
No. correct x0.039 0.784
WRAT-R
Reading Standard Score 0.134 0.340
Attention
Cancellations
Nonverbal, time 0.050 0.725
Verbal, time 0.122 0.384
CPT
X-degraded, reaction time# x0.062 0.665
X-degraded, no. correct x0.075 0.599
X-degraded, omission 0.080 0.579
X-degraded, no. incorrect# x0.022 0.876
X-degraded, sensitivity# x0.087 0.552
AX, reaction time x0.103 0.464
AX, no. correct# x0.143 0.308
AX, omission# 0.172 0.219
AX, no. incorrect# x0.135 0.335
AX, sensitivity# x0.036 0.796
Trail Making Test
Part A, time in seconds x0.087 0.536
Memory
WMS-R
Logical Memory, I 0.195 0.161
Logical Memory, II 0.090 0.572
Visual Reproduction, I# 0.001 0.993
Visual Reproduction, II 0.023 0.868
CVLT
Trials 1–5, total correct 0.110 0.437
List B, total correct# 0.013 0.926
Short Delay Free Recall, no. correct 0.113 0.425
Short Delay Cued Recall, no. correct 0.226 0.108
Long Delay Free Recall, no. correct 0.041 0.775
Long Delay Cued Recall, no. correct x0.021 0.883
Recognition Hits# 0.113 0.427
Rey-Osterrieth
Copy Accuracy# x0.017 0.906
Immediate Recall Accuracy x0.032 0.821
Delayed Recall Accuracy x0.094 0.503
Executive functioning
WCST
Categories completed# 0.019 0.895






coeﬃcients, r p value
Stroop Test
Age Corrected Color/Word Score 0.174 0.218
Cancellations
Nonverbal, Organization Score# 0.095 0.494
Verbal, Organization Score# 0.039 0.780
Trail Making Test
B – A, time in seconds# 0.087 0.534
Rey-Osterrieth
Copy Organization# 0.034 0.807
Immediate Recall Organization# x0.195 0.161
Delayed Recall Organization# 0.004 0.977
Motor skills
Finger Tapping
Dominant hand x0.183 0.190
Non-dominant hand 0.088 0.523
Grooved Pegboard
Time, dominant hand 0.181 0.196
Time, non-dominant hand 0.055 0.697
CPT, Continuous Performance Task; WAIS-R, Wechsler Adult
Intelligence Scale – Revised; WRAT-R, Wide Range Achievement
Test – Revised.
* p<0.05.
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correlations for the number of correct responses
(r=0.036; p=0.798) and the number of omis-
sions (r=x0.04; p=0.775) with marijuana use
days.
DISCUSSION
We examined neuropsychological functioning
in 54 male monozygotic twin pairs discordant
for prior regular marijuana use. To address the
risk of Type I errors, we ﬁrst performed a small
number of multivariate tests, comparing users
and non-users on their performance across
speciﬁc cognitive domains. Multivariate analy-
sis yielded signiﬁcant group diﬀerences on the
general intelligence domain. We then examined
group diﬀerences on individual subtests. Out of
the 16 tests making up the general intelligence
domain, marijuana users performed signiﬁ-
cantly worse than non-users on only the block
design subtest of the WAIS-R. There was a
trend in this domain for users to have a higher
performance IQ than non-users as measured
by the WAIS-R, a higher score on the picture
arrangement subtest of the WAIS-R, and a
higher reading standard score on the WRAT-R.
Based on ﬁnding only one signiﬁcant compari-
son between users and non-users on the tests
comprising this domain, and the fact that there
existed a trend of users performing better than
non-users on several tests, we concluded that
the eﬀects observed in our multivariate analysis
do not support the existence of meaningful
long-term residual eﬀects of regular marijuana
use. The absence of any signiﬁcant dose–
response relationship between the increased
use of marijuana, as measured by the number
of use days, and cognitive abilities further
strengthens this conclusion.
We considered the possible implications of
the nominal p-values comparing users to non-
users on both the long delay free and cued recall
conditions of the CVLT, the latter at the trend
level. Previous studies found diﬀerences between
heavy and light users on these two CVLT con-
ditions, but also found diﬀerences on several
other CVLT measures that failed to reach
signiﬁcance in our sample (Pope & Yurgelun-
Todd, 1996). Users, in our sample, performed
no worse than non-users on theWMS-R Logical
Memory II subtest, which assesses delayed recall
for contextually meaningful verbal material.
Similarly, while the possibility of poorer per-
formance on the FTT (non-dominant hand
only) suggested by the nominal p value could
be a sign of reduced manual dexterity, users
performed equally well as non-users on the
Grooved Pegboard, an even more complex and
neurologically sensitive measure of motor
dexterity and speed (Lezak, 1995). The lack of
supporting evidence for these cognitive deﬁcits
leads us to believe that, once again, our ﬁndings
may simply reﬂect the large number of signiﬁ-
cance tests performed. Pope & Yurgelun-Todd
(1996), while acknowledging the large number
of individual comparisons they made, never-
theless point out that almost every diﬀerence,
whether signiﬁcant or not, was in the direction
of poorer performance by heavy users than by
light users. This is not true of our results.
Given our failure to detect much in the way
of diﬀerences between users and their co-twins,
we considered the possibility that low statistical
power could account for this. To evaluate this
possibility, we examined the statistical power
of our matched pairs t tests. One factor that
inﬂuences the power of a matched pairs t test is
the correlation within the pair. For the variables
on which we conducted t tests, the within pair
correlations ranged from a low of r=0.22 to a
high correlation of r=0.83 with a mean corre-
lation of r=0.50. Based on 54 pairs of twins, an
alpha of 0.05, and Cohen’s (1988) deﬁnitions of
eﬀect sizes, we calculated that for the variable
with the lowest within pair correlation we had a
power of 21.1% to detect a small eﬀect, a power
of 82.4% to detect a medium eﬀect, and a power
of 99.6% to detect a large eﬀect. For the vari-
able with the highest within pair correlation we
had a power of 68.4% to detect a small eﬀect
and power greater than 99% to detect a medium
eﬀect. For the average within pair correlation
we had a power of 30.2% to detect a small eﬀect
size, a power of 95% to detect a medium eﬀect,
and a power of over 99% to detect a large
eﬀect. Thus, we do not believe that our failure
to observe consistent diﬀerences between mari-
juana using twins and their non-marijuana using
identical co-twins is likely to reﬂect inadequate
statistical power. Real diﬀerences too small to
be detected by our study are unlikely to have
much practical importance.
These results are compatible with previous
ﬁndings by our group, which found that a
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history of regular marijuana use was not associ-
ated with adverse eﬀects on socio-demographic
characteristics, physical health, or mental health
(Eisen et al. 2002), as well as those of other
studies that found no, or few, diﬀerences be-
tween marijuana users and non-users on neuro-
psychological functioning. The research design
used in the present study provides several
methodological advantages over prior research
on the cognitive eﬀects of marijuana use. First,
the sample is drawn from the VET registry,
which is population-based. Many previous
studies have used subjects obtained from treat-
ment-seeking clinical samples (Gonzalez et al.
2002). Individuals with cognitive impairment
may be disproportionately represented among
clinical groups, thus increasing the observed
eﬀects of marijuana use. Second, the use of
monozygotic twins as controls minimizes the
problem of confounding variables, such as pre-
morbid diﬀerences in cognitive functioning, as
monozygotic twins share all of their genes and
many of the same childhood experiences. Third,
the marijuana-using twin had smoked a con-
siderable amount of marijuana. The mean
number of days on which marijuana was used
was 916 over a mean of 5.8 years, with 39% of
users reporting a minimum of between 301 and
1000 days of use, and 24% reporting a mini-
mum of between 1001 and 7000 days. Fourth,
a minimum of 1 year had passed since the
marijuana-using twin had last used the drug,
and a mean of almost 20 years had passed since
the last time marijuana had been used regularly.
This precluded the possibility that positive re-
sults could be attributed to either a withdrawal
eﬀect or a drug residue eﬀect. Any cognitive
deﬁciencies observed could reasonably be at-
tributed to a long-term CNS alteration eﬀect.
Finally, our study excluded twin pairs in which
either member reported ever using any other
illicit drug at least once weekly at any time
in his life, or ever experienced symptoms of
alcohol withdrawal. This reduced the likelihood
that observed diﬀerences between twin sib-
lings might be attributable to drugs other than
marijuana.
Our study does have several potential limi-
tations. First, because only about half of the
eligible pairs participated in the study, it is
possible that our results were inﬂuenced by non-
response bias. Individuals whose functioning
had been compromised by heavy marijuana use
may have been unable or unwilling to partici-
pate. We attempted to examine this possibility
by comparing 1992 data on the eligible pairs
who did not participate to corresponding data
from participating pairs. No diﬀerences were
detected in age, race, employment status, edu-
cational attainment and a variety of psychiatric
disorders. Nevertheless we cannot exclude the
possibility that participation bias may have
prevented us from detecting adverse eﬀects of
marijuana use on cognitive functioning.
Second, the assessment of regular marijuana
use is based on retrospective self-report, and
thus its validity is unknown. While the reliability
and validity of self-reported drug use data have
generally been demonstrated to be satisfactory
(Brown et al. 1992; Harrison et al. 1993), it is
not known if this validity extends to recall of
marijuana use patterns 20 years after regular
use has ended. Similarly, although subjects
denied recent substance use, we cannot be
absolutely certain that some participants had
not used drugs or alcohol in the days immedi-
ately prior to testing, leaving a possible drug
residue in their bodies. Because of the possibility
that marijuana-using twins might be more likely
to use other substances, any drug residue eﬀects
might be more likely in the marijuana-using
twin, biasing the results in the direction of
greater impairment. Additionally, if the mari-
juana users had consumed in the past greater
quantities of drugs other than marijuana that
could produce more neuropsychological impair-
ment among the marijuana users as a conse-
quence of the other drugs. But the absence of
impairment in the marijuana group reduces
both of these concerns.
Third, it should be noted that the subjects
in our sample by and large displayed moderate
levels of marijuana use, and that our ﬁndings
may not generalize to the eﬀects brought on
by very heavy marijuana use. Bolla et al. (2002)
found evidence of neurocognitive deﬁcits even
after 4 weeks of abstinence in subjects who
usedmarijuana as frequently as 13 times per day.
Although we used a diﬀerent method to deter-
mine the frequency of marijuana use, we can
conclude that our sample did not approach this
level of abuse. Our data, however, are probably
more reﬂective of the typical marijuana user,
and as such provide more generalizable results.
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Fourth, although our design allows us to
control for pre-existing diﬀerences in the family
environment or genetic factors between regular
marijuana users and non-users, it does not
preclude the possibility that some environ-
mental factor not shared by twins (e.g. an early
childhood head injury) might increase the risk
of future marijuana usage and produce neuro-
psychological impairment. This possibility of a
third factor predisposing towards both mari-
juana usage and neuropsychological impairment
independent of genetic and family environ-
mental inﬂuences would be more of a concern
if we had observed signiﬁcant diﬀerences be-
tween the groups.
Fifth, our sample consisted entirely of males,
and thus our results may not generalize to fe-
males. As women have been underrepresented
in research on the consequences of drug abuse,
and as Pope et al. (1997) found sex-speciﬁc
residual eﬀects of marijuana use on cognitive
functioning, it is important to study marijuana-
using women before conclusions can be drawn
regarding the drug’s eﬀects.
Finally, a recent study by Pope et al. (2003)
has provided evidence of a possible signiﬁcant
eﬀect for early versus late onset marijuana use
and subsequent cognitive deﬁcits. Speciﬁcally,
they found that individuals who began smoking
marijuana before age 17 showed signiﬁcant
deﬁcits when compared to those who began
at age 17 or later. The authors hypothesize that
this diﬀerence could be due to an innate cog-
nitive deﬁcit that predisposes an individual to
begin using marijuana at an early age, a dis-
ruption in education brought on by the early
use, or a neurotoxic eﬀect of marijuana during
early adolescence. In our sample only two sub-
jects reported having tried marijuana before
age 17, and none initiated regular marijuana
use prior to that age. As a result, we were
unable to separate our sample into early and
late onset users, and could not appropriately
address age of onset in our analyses. Therefore,
if an innate cognitive impairment predisposes
an individual to early but not late onset mari-
juana use, our study would not be able address
this eﬀect. The lack of early onset users in
our sample could be the result of prior screening
at the time of military induction, with early
regular users being found unﬁt for military
service.
Despite employing a rigorous research design,
this study fails to ﬁnd clear evidence in support
of the hypothesis that regular marijuana use
causes long-term residual CNS alternations.
This suggests the need to study other illicit drugs
whose regular use is assumed to have detrimen-
tal eﬀects on long term-cognitive functioning.
ACKNOWLEDGEMENTS
Supported by a grant (DA04604) from the
National Institute on Drug Abuse to Dr Ming
T. Tsuang. The United States Department of
Veterans Aﬀairs has provided ﬁnancial support
for the development and maintenance of the
Vietnam Era Twin (VET) registry. Numerous
organizations have provided invaluable assist-
ance in the conduct of this study, including:
Department of Defense; National Personnel
Records Center, National Archives and Records
Administration; the Internal Revenue Service ;
National Opinion Research Center; National
Research Council, National Academy of Sci-
ences; the Institute for Survey Research, Temple
University. Most importantly, the authors
gratefully acknowledge the continued cooper-
ation and participation of the members of the
VET registry and their families. Without their
contribution this research would not have been
possible. An earlier version of this paper was
presented at the Eighth International Twin




APA (1987). Diagnostic and Statistical Manual of Mental Disorders
(3rd edn, Revised). American Psychiatric Association: Wash-
ington, DC.
Block, R. I. (1996). Does heavy marijuana use impair human
cognition and brain function? Journal of the American Medical
Association 275, 560–561.
Block, R. I. & Ghoneim, M. M. (1993). Eﬀects of chronic marijuana
use on human cognition. Psychopharmacology 110, 219–228.
Bolla, K. I., Brown, K., Eldreth, D., Tate, K. & Cadet, J. L. (2002).
Dose-related neurocognitive eﬀects of marijuana use. Neurology
59, 1337–1343.
Brown, J., Kranzler, H. R. & Del Boca, F. K. (1992). Self-reports
by alcohol and drug abuse inpatients : factors aﬀecting reliability
and validity. British Journal of Addiction 87, 1013–1024.
Cardon, L. R. & Fulker, D. W. (1993). Genetics of speciﬁc cognitive
abilities. In Nature, Nurture, and Psychology (ed. R. Plomin and
G. E. McClearn), pp. 99–120. American Psychological Associ-
ation: Washington, DC.
Neuropsychological consequences of regular marijuana use 1249
Cohen, J. (1988). Statistical Power Analysis for the Behavioral
Sciences. Erlbaum Associates : Hillsdale, NJ.
Davies, D. R. & Parasuraman, R. (1982). The Psychology of
Vigilance. Psychological Assessment Resources Inc. : Orlando, FL.
Delis, D. C., Levin, B. E., Kaplan, E. & Ober, B. A. (1987). California
Verbal Learning Test: Adult Version. The Psychological Corpor-
ation: San Antonio, TX.
Eisen, S., True, W., Goldberg, J., Henderson, W. & Robinette, C. D.
(1987). The Vietnam Era Twin (VET) registry: method of
construction. Acta Genet Med Gemellol (Roma) 36, 61–66.
Eisen, S., Neuman, R., Goldberg, J., Rice, J. & True, W. (1989).
Determining zygosity in the Vietnam era twin registry: an
approach using questionnaires. Clinical Genetics 35, 423–432.
Eisen, S., Chantarujikapong, S., Xian, H., Lyons, M. J., Toomey, R.,
True, W. R., Scherrer, J. F., Goldberg, J. & Tsuang, M. T. (2000).
Does marijuana use have residual adverse eﬀects on self-reported
health measures, socio-demographics and quality of life? A mono-
zygotic co-twin control study in men. Addiction 97, 1137–1144.
Ellis, G. M., Mann, M. A., Judson, B. A., Schramm, N. T. &
Tashchian, A. (1985). Excretion patterns of cannabinoid metab-
olites after last use in a group of chronic users. Clinical Pharma-
cology and Therapeutics 38, 572–578.
Fadda, F. & Rossetti, Z. L. (1998). Chronic ethanol consumption:
from neuroadaptation to neurodegeneration. Progress in Neuro-
biology 56, 385–431.
Fletcher, J. M., Page, J. B., Francis, D. J., Copeland, K., Naus, M. J.,
Davis, C. M., Morris, R., Krauskopf, D. & Satz, P. (1996). Cogni-
tive correlates of long-term cannabis use in Costa Rican men.
Archives of General Psychiatry 53, 1051–1057.
Gonzalez, R., Carey, C. & Grant, I. (2002). Nonacute (residual)
neuropsychological eﬀects of cannabis use : a qualitative analysis
and systematic review. Journal of Clinical Pharmocology 42,
48S–57S.
Grant, I., Gonzalez, R., Carey, C. L., Natarajan, L. & Wolfson, T.
(2003). Non-acute (residual) neurocognitive eﬀects of cannabis
use : a meta-analytic study. Journal of the International Neuro-
psychological Society 9, 679–689.
Halstead, W. C. (1947). Brain and Intelligence. University of Chicago
Press: Chicago.
Harrison, E. R., Haaga, J. & Richards, T. (1993). Self-reported drug
use data: what do they reveal? American Journal of Drug and
Alcohol Abuse 19, 423–441.
Heaton, R. K. (1981). Wisconsin Card Sorting Test (WCST).
Psychological Assessment Resources : Odessa, FL.
Henderson, W. G., Eisen, S., Goldberg, J., True, W. R., Barnes, J. E.,
& Vitek, M. E. (1990). The Vietnam Era Twin Registry: a resource
for medical research. Public Health Reports 105, 368–373.
Jastak, S. & Wilkinson, G. S. (1984). Wide Range Achievement
Test – Revised. Jastak Assessment Systems: Wilmington, DE.
Lezak, M. D. (1995). Neuropsychological Assessment (3rd edn).
New York: Oxford University Press.
Lyketsos, C. G., Garrett, E., Liang, K. Y. & Anthony, J. C. (1999).
Cannabis use and cognitive decline in persons under 65 years of
age. American Journal of Epidemiology 49, 794–800.
Matthews, C. G. & Klove, H. (1964). Instruction Manual for the Adult
Neuropsychology Test Battery. University of Wisconsin Medical
School : Madison, WI.
Mendhiratta, S. S., Varma, V. K., Dang, R., Malhotra, A. K.,
Das, K. & Nehra, R. (1988). Cannabis and cognitive functions:
a re-evaluation study. British Journal of Addiction 83, 749–753.
Mesulam, M. M. (1985). Principles of Behavioral Neurology. F. A.
Davis : Philadelphia.
Osterrieth, P. A. (1944). Le test de copie d’une ﬁgure complexe.
Archives de Psychologie 30, 206–356; translated by J. Corwin &
F. W. Bylsma (1993). The Clinical Neuropsychologist 7, 9–15.
Pope, H. G., Gruber, A. J., Hudson, J. I., Cohane, G., Huestis, M. A.
& Yurgelun-Todd, D. (2003). Early-onset cannabis use and cog-
nitive deﬁcits: what is the nature of the association? Drug and
Alcohol Dependence 69, 303–310.
Pope, H. G., Gruber, A. M., Hudson, J. I., Huestis, M. A. &
Yurgelun-Todd, D. (2002). Cognitive measures in long-term
cannabis users. Journal of Clinical Pharmacology 42, 41S–47S.
Pope, H. G., Gruber, A. J. & Yurgelun-Todd, D. (1995). The residual
neuropsychological eﬀects of cannabis: the current status of re-
search. Drug and Alcohol Dependence 38, 25–34.
Pope, H. G., Jacobs, A., Mialet, J. O., Yurgelun-Todd, D. & Gruber,
S. (1997). Evidence for a sex-speciﬁc residual eﬀect of cannabis
on visuospatial memory. Psychotherapy and Psychosomatics 66,
179–184.
Pope, H. G. & Yurgelun-Todd, D. (1996). The residual cognitive
eﬀects of heavy marijuana use in college students. Journal of the
American Medical Association 275, 521–527.
Raven, J. C. (1982). Revised Manual for Raven’s Progressive Matrices
and Vocabulary Scale. NFER Nelson: Windsor, UK.
Rey, A. (1941). Psychological examination of traumatic encepha-
lopathy. Archives de Psychologie 28, 286–340; sections translated
by J. Corwin and F. W. Bylsma (1993). The Clinical Neuro-
psychologist 7, 4–9.
Robins, L., Helzer, J., Cottler, L. & Goldring, E. (1989). NIMH
Diagnostic Interview Schedule Version III Revised (DIS-III-R).
Department of Psychiatry, Washington University Medical
School : St Louis, MO.
Rosvold, H. E., Mirsky, A. F., Sarason, I., Bransome, E. D. & Beck,
L. H. (1956). A continuous performance test of brain damage.
Journal of Consulting Psychology 20, 343–350.
Schwartz, R. H., Gruenewald, P. J., Klitzner, M. & Fedio, P.
(1989). Short-term memory impairment on cannabis-dependent
adolescents. American Journal of Diseases of Children 143,
1214–1219.
Solowij, N., Stephens, R. S., Roﬀman, R. A., Babor, T., Kadden, R.,
Miller, M., Christiansen, K., McRee, B. & Vendetti, J. (2002).
Cognitive functioning of long-term heavy cannabis users seeking
treatment. Journal of the American Medical Association 287,
1123–1131.
Solowij, N., Michie, P. T. & Fox, A. M. (1991). Eﬀects of
long-term cannabis use on selective attention: an event-related
potential study. Pharmacology Biochemistry and Behavior 40,
683–688.
Stroop, J. R. (1935). Studies of interference in serial verbal reactions.
Journal of Experimental Psychology 18, 643–662.
Toomey, R., Lyons, M. J., Eisen, S. A., Xian, H., Chantarujikapong,
S., Seidman, L. J., Faraone, S. V. & Tsuang, M. T. (2003). A twin
study of the neuropsychological consequences of stimulant abuse.
Archives of General Psychiatry 60, 303–310.
Tsuang, M. T., Bar, J. L., Harley, R. M. & Lyons, M. J. (2001). The
Harvard twin study of substance abuse: what we have learned.
Harvard Review of Psychiatry 9, 267–279.
Varma, V. K., Malhotra, A. K., Dang, R., Das, K. & Nehra, R. (2000).
Cannabis and cognitive functions: a prospective study. Drug and
Alcohol Dependence 21, 147–152.
Wechsler, D. (1981). WAIS-R Manual: Wechsler Adult Intelligence
Scale – Revised. Psychological Corporation: San Antonio, TX.
Wechsler, D. (1987). Wechsler Memory Scale – Revised Manual.
Psychological Corporation: San Antonio, TX.
1250 M. J. Lyons et al.
